Dolasetron Injection and Aprindine: Interaction Details

Brand names
Dolasetron Injection
Anzemet
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Dolasetron Injection and Aprindine interaction:

Share

Share this interaction

Dolasetron Injection

Brand name
  • Anzemet

We don't have a drug information page for Dolasetron Injection yet. Have a question about Dolasetron Injection? Ask a pharmacist, free →

Aprindine

We don't have a drug information page for Aprindine yet. Have a question about Aprindine? Ask a pharmacist, free →

What Happens When You Take Dolasetron Injection With Aprindine

What can happen when they are taken together (rated Major)

An increased risk of (, , cardiac arrest)

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

No formal drug interaction studies have been conducted, yet combining Class I antiarrhythmics with other agents known to prolong the is not recommended.8 The dolasetron manufacturer, without citing supporting data, advises caution when dolasetron is given together with any other drug capable of prolonging the QTc interval.9

The Dolasetron Injection and Aprindine Interaction, Explained

Dolasetron (Anzemet) is an anti-nausea medicine given by injection. Aprindine is a heart rhythm medicine. Both can affect the heart's electrical timing, called the . Taking them together could stretch that timing further, which raises the chance of a dangerous heart rhythm problem.

This warning is based on how the drugs work, not on studies of people taking both. Still, it is taken seriously, and the combination is not recommended. Please keep taking your medicines as prescribed and talk with your pharmacist or doctor. Your care team can review your options and watch your heart closely if needed.

Mechanism: . Dolasetron (via its active hydrodolasetron) prolongs , and aprindine is a Class I antiarrhythmic with proarrhythmic and QT-prolonging potential. This is not a interaction.

  • Risk: QT prolongation, , cardiac arrest.
  • Evidence: theoretical; no formal interaction studies. Onset unspecified.
  • Severity: major.
  • Management: is not recommended. If unavoidable, consider an alternative antiemetic without QT effect, and correct and . Obtain baseline and follow-up monitoring.

See the 9 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Dolasetron Injection and Aprindine Interact

The likely mechanism

effects on

In short: Dolasetron injection and aprindine both lengthen the QT interval, a measure of the heart’s rhythm, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Dolasetron Injection and Aprindine Interaction

The documented advice is that these two medicines not be used together when possible. Your care team may choose a different anti-nausea medicine, or review whether the heart rhythm medicine plan still fits.

  • Keep taking both exactly as prescribed until you speak with your prescriber or pharmacist.
  • Tell them about all other medicines you take, especially any that affect heart rhythm.
  • If both must be used, your team may monitor you more closely.
  • Seek urgent help for fainting, a racing or irregular heartbeat, or severe dizziness.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Dolasetron Injection or Aprindine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

4 reports from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Torsades de pointes as a manifestation of mexiletine toxicity

    A case of (a variant of ventricular ) has been reported in a 59-year-old male who was receiving mexiletine 100 mg orally every 6 hours.1 After the drug was discontinued, the ventricular tachycardia did not return.

  2. Report 2 · Study title

    Prescribing information: Tambocor, flecainide acetate

    In most patients, flecainide slows conduction in the heart, producing dose-related prolongation of the PR, QRS, and QT intervals.2

  3. Report 3 · Study title

    Lorcainide treatment of Wolff-Parkinson-White syndrome in children and adolescents

    Lorcainide has been reported to widen the QRS complex and prolong the , and it only rarely produces a negative inotropic effect (less than 1%). Like all antiarrhythmic agents, lorcainide may provoke rhythm disturbances.3456

  4. Report 4 · Study title

    Aprindine-induced polymorphous ventricular tachycardia

    Polymorphous ventricular (PVT; ) induced by aprindine has been reported in sustained and nonsustained forms after oral and intravenous dosing (125 to 600 mg/day). PVT presented with and recurrent syncope.

    It developed within 10 days of starting aprindine and resolved within 2 to 48 hours of stopping the drug. The returned to predrug values once aprindine was discontinued.

    In some cases PVT ended spontaneously, while in others electrical cardioversion was required. In one case, may have contributed to the proarrhythmic effect. Patients with an acquired QT syndrome induced by an antiarrhythmic drug may be predisposed to aprindine-induced PVT.7

Dolasetron Injection and Aprindine: Common Questions

How serious is the Dolasetron Injection and Aprindine interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Dolasetron Injection and Aprindine interaction managed?

The documented advice is that these two medicines not be used together when possible. Your care team may choose a different anti-nausea medicine, or review whether the heart rhythm medicine plan still fits. Keep taking both exactly as prescribed until you speak with your prescriber or pharmacist. Tell them about all other medicines you take, especially any that affect heart rhythm. If both must be… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Dolasetron Injection and Aprindine Interaction

Ask in your own words about taking Dolasetron Injection and Aprindine together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (9)

  1. Cocco G, Strozzi C, Chu D, et al: Torsades de pointes as a manifestation of mexiletine toxicity. Am Heart J 1980; 100:878-880. PubMed
  2. Product Information: Tambocor(R), flecainide acetate. 3M Pharmaceuticals, Northridge, CA, 1998. DailyMed
  3. Samanek M, Hrobonova V, & Bartakova H: Lorcainide treatment of Wolff-Parkinson-White syndrome in children and adolescents. Pediatr Cardiol 1987; 8:3-9. PubMed
  4. McDevitt DG: The clinical pharmacology of lidocaine congeners - Review of encainide, flecainide, lorcainide and tocainide. Eur Heart J 1984; 5(suppl B):63-66. PubMed
  5. Myburgh DP, Goldman AP, & Schamroth JM: Lorcainide - an anti-arrhythmic agent for ventricular arrhythmias. S Afr Med J 1980; 57:236-239.
  6. Kasper W, Meinertz T, Kersting F, et al: Electrophysiological actions of lorcainide in patients with cardiac disease. J Cardiovasc Pharmacol 1979; 1:343-352. PubMed
  7. Scagliotti D, Strasberg B, Hai HA, et al: Aprindine-induced polymorphous ventricular tachycardia. Am J Cardiol 1982; 49:1297-1300. PubMed
  8. Product Information: Tambocor(R), flecainide acetate. 3M Pharmaceuticals, Northridge, CA, 1998. DailyMed
  9. Product Information: Anzemet(R), dolasetron. Hoechst Marion Roussel, Inc. Kansas City, MO, 1997. DailyMed
Was this write-up helpful?

Other Serious Interactions of Dolasetron Injection and Aprindine

Also serious with Dolasetron Injection

Also serious with Aprindine

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.